Improving safety practices for oncology nurses handling chemotherapy
Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses
This study is working to keep oncology nurses safe by creating a new program called WISH that teaches them how to handle chemotherapy safely and helps them talk about any issues they face, so they can better protect themselves while caring for patients.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10784024 on NIH RePORTER |
What this research studies
This research aims to enhance the safety of oncology nurses by promoting adherence to chemotherapy handling guidelines. It involves developing a novel program called WISH, which includes an educational component and debriefing sessions to address chemotherapy exposure incidents. The program will be validated through expert evaluations and focus groups with oncology nurses to ensure its effectiveness and relevance. By improving adherence to safety protocols, the research seeks to reduce the risks associated with chemotherapy exposure for nurses.
Who could benefit from this research
Good fit: Ideal candidates for this research are oncology nurses who handle chemotherapy drugs in their workplace.
Not a fit: Patients who are not oncology nurses or do not work in environments where chemotherapy is handled will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the occupational hazards faced by oncology nurses, leading to improved health outcomes.
How similar studies have performed: While there may be existing programs aimed at improving safety in healthcare settings, this specific approach to enhancing chemotherapy handling guidelines among oncology nurses is relatively novel.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Abu-Alhaija, Dania — University of Cincinnati
- Study coordinator: Abu-Alhaija, Dania
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.